| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |